IndiaCOVID-19Ministry of Health and Family WelfareHealth

India’s Cumulative COVID-19 Vaccination Coverage exceeds 169.63 Cr

More than 14.70 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 96.19%

83,876 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 11,08,938

Weekly Positivity Rate is presently at 9.18%

With the administration of more than 14.70 lakh Doses (14,70,053) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 169.63 Cr (1,69,63,80,755) as per provisional reports till 7 am today.

This has been achieved through 1,88,18,564 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,03,97,781
2nd Dose 99,03,933
Precaution Dose 36,60,707
FLWs 1st Dose 1,84,01,732
2nd Dose 1,73,20,283
Precaution Dose 47,91,948
Age Group 15-18 years 1st Dose 4,94,74,550
2nd Dose 58,41,998
Age Group 18-44 years 1st Dose 54,49,45,193
2nd Dose 41,62,01,224
Age Group 45-59 years 1st Dose 20,10,28,565
2nd Dose 17,40,94,991
Over 60 years 1st Dose 12,54,12,674
2nd Dose 10,84,67,154
Precaution Dose 64,38,022
Precaution Dose 1,48,90,677
Total 1,69,63,80,755

 

1,99,054 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,06,60,202.

Consequently, India’s recovery rate stands at 96.19%.

83,876 new cases were reported in the last 24 hours.

India’s Active Caseload is presently at 11,08,938. Active cases constitute 2.62% of the country’s total Positive Cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 11,56,363 tests being conducted. India has so far conducted over 74.15 Cr (74,15,61,587) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 9.18% and the Daily Positivity rate is reported to be 7.25%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker